NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsLowNeutral
Announced Mon, 5 May · 09:57 IST

Neuland Laboratories Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Neuland Laboratories has informed the exchanges that it will announce its financial results for the fourth quarter and full financial year ended March 31, 2025 on May 15, 2025. Following the results announcement, the company's management will host an investor earnings call on the same day at 17:00 hrs IST. The filing was made under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30) by the Company Secretary, Sarada Bhamidipati. Neuland is a Hyderabad-based API manufacturer with over 4 decades of experience, serving customers in nearly 80 countries with around 980 regulatory filings and 72 active US DMFs.

Likely market impact

This is a routine advance intimation of the upcoming Q4 and FY25 earnings announcement. Investors should watch for the results and management commentary on the May 15 call for clarity on revenue, margins, and FY26 outlook, which could move the stock.